The renewed Women’s Health Strategy outlines national plans to reduce waiting times, set new pain relief standards and give women direct influence over services through feedback-linked trials.
On 15 April 2026 the government published the refreshed Women’s Health Strategy for England, aligning it with the existing 10 Year Health Plan. The plan promises to shift power toward patients by prioritising women’s voices, increasing choice and strengthening oversight of care.
Central aims include faster access to specialist diagnosis and treatment for conditions like endometriosis and fibroids, better pain management for invasive procedures, and new ways for women’s feedback to drive improvement.
The strategy stresses that services should be responsive across the life course, from menstrual health through to menopause and reproductive loss.
It pledges to use digital tools and expanded local diagnostics so that women are seen, diagnosed and treated closer to home. The document also emphasises research, innovation and partnership working to close evidence gaps and make sure clinical practice reflects women’s needs.
What changes are being introduced
The refreshed strategy introduces several concrete measures intended to reduce delays and improve experiences. A new standard of care will ensure women are routinely offered appropriate pain relief for common invasive gynaecological procedures such as contraceptive coil fitting and hysteroscopies. A trial will explore linking women’s service feedback to provider payments, creating direct accountability for patient experience. Additionally, the plan proposes a single referral point to simplify access and make sure women are directed to the right specialist first time.
Targets for diagnosis, waiting lists and community care
Long diagnostic waits particularly for endometriosis have been highlighted as unacceptable; the strategy sets out reforms to clinical pathways to speed up assessment and treatment for heavy periods, urogynaecology and menopause-related issues. The government notes that there are over 565,000 women waiting for gynaecological care, while claiming gynaecology waiting lists have fallen by more than 30,000 since June 2026. To cut waits further, the plan expands community diagnostics such as blood tests and MRIs and embeds women’s health hubs within neighbourhood services.
Education, innovation and regional support
Education and technology receive specific investment. The strategy launches a £1 million menstrual education programme to help girls and young people recognise when periods are unhealthy, and a £1.5 million Femtech challenge fund to accelerate promising tools. There will also be funding for a specialist centre in each region to trial group-based approaches and build local expertise. The National Institute for Health and Care Research (NIHR) will fund targeted studies, embed new sex and gender research policies, and support trials of novel treatments.
Accountability, advocacy and professional response
The strategy elevates accountability by creating a formal mechanism for patient feedback to influence service improvement and commissioning. This trial to link feedback to funding is intended to tackle what campaigners describe as medical misogyny — the pattern where women’s symptoms are dismissed or minimised. Health leaders including the Health and Social Care Secretary and NHS clinical directors have framed this work as correcting long-standing gaps in recognition, pain management and referral pathways.
Voices from the sector
Professional and voluntary organisations have responded with cautious optimism. Clinical leaders welcomed commitments to reduce gynaecology backlogs and support abortion and contraceptive access, while charities highlighted the need for clear delivery plans and sustained investment. Grassroots groups and research bodies stressed the importance of co-producing services with women, ensuring that the women’s voices partnership and regional centres genuinely reflect diverse experiences and lead to measurable improvement.
Overall, the renewed Women’s Health Strategy sets out a programme of service redesign, education, research and accountability intended to ensure women receive timely diagnosis, appropriate pain relief and a stronger role in shaping their care. Delivery depends on sustained funding, coordinated local implementation and transparent reporting so that the strategy moves from commitments to real changes in women’s day-to-day health experiences.
